SEC 13F Intelligence

Boxer Capital, LLC / BMRN

Boxer Capital, LLC’s Biomarin Pharmaceutical Inc Position

Does Boxer Capital, LLC own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 250.0K shares worth $21M in Q2 2021; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$21M
Q2 2021
Shares
250.0K
% of Portfolio
+0.74%
Quarters Held
8
position exited

Position History BMRN

Reported value by quarter
Q3 ’19: $30MQ3 ’19Q4 ’19: $21MQ4 ’19Q1 ’20: $21MQ1 ’20Q2 ’20: $31MQ2 ’20Q3 ’20: $19MQ3 ’20Q4 ’20: $22MQ4 ’20Q1 ’21: $19MQ1 ’21Q2 ’21: $21MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021250.0K$21M+0.74%
Q1 2021250.0K$19M+0.64%
Q4 2020250.0K$22M+0.70%
Q3 2020250.0K$19M+0.66%
Q2 2020250.0K$31M+1.36%
Q1 2020250.0K$21M+1.44%
Q4 2019250.0K$21M+1.20%
Q3 2019450.0K$30M+2.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of BMRN.